Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA awards orphan drug status to Pluristem's PLX-R18 for ARS

Oct. 20, 2017

Otsuka submits NDA for nalmefene in Japan

Oct. 19, 2017

Anti-ALDH2 gene therapy could discourage alcohol intake

Oct. 11, 2017

NIH grant supports exploration of NVP-015 for use against chemical threats

Oct. 5, 2017

Emergent BioSolutions completes acquisition of raxibacumab from GSK

Oct. 4, 2017

Opiant and Titan to develop product for opioid use disorder

Oct. 3, 2017

NIDA grant supports Camino Pharma's development of compounds for substance use disorders

Sep. 29, 2017

Aeolus Pharmaceuticals' AEOL-10150 safe and well-tolerated in phase I study

Sep. 20, 2017

Emergent Biosolutions awarded funding to develop antidote spray for cyanide poisoning

Sep. 20, 2017

FDA accepts Camurus' NDA for CAM-2038 buprenorphine depots

Sep. 19, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 27, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...